Class Action
Feb. 18, 2026
Monsanto announces $7.25B class settlement in Roundup cancer litigation
The proposed agreement, filed for preliminary approval in St. Louis, is designed to resolve both current and future claims from individuals alleging they developed Non-Hodgkin lymphoma from the glyphosate-based herbicide.
Bayer AG subsidiary Monsanto announced a $7.25 billion nationwide class settlement on Tuesday aimed at resolving the longstanding legal battle over its glyphosate-based herbicide, Roundup. The proposed agreement is designed to address both current and future claims from individuals alleging they developed non-Hodgkin lymphoma due to Roundup exposure.
Under the terms of the settlement, which was filed for preliminary approval in state court in St. Louis, Missouri, Monsanto will pro...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In